Bio-Thera Solutions, Ltd. (SHA:688177)
22.29
+1.79 (8.73%)
At close: Mar 27, 2026
Bio-Thera Solutions Market Cap
Bio-Thera Solutions has a market cap or net worth of 9.23 billion as of March 27, 2026. Its market cap has increased by 5.14% in one year.
Market Cap
9.23B
Enterprise Value
9.61B
Revenue
933.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.29
Market Cap Chart
Since February 21, 2020, Bio-Thera Solutions's market cap has decreased from 24.93B to 9.23B, a decrease of -62.97%. That is a compound annual growth rate of -15.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 9.23B | -3.67% |
| Dec 31, 2025 | 9.58B | 19.40% |
| Dec 31, 2024 | 8.02B | -53.01% |
| Dec 29, 2023 | 17.08B | 89.35% |
| Dec 30, 2022 | 9.02B | -15.68% |
| Dec 31, 2021 | 10.70B | -18.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Hotgen Biotech | 9.78B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 9.33B |
| HitGen | 9.29B |
| Chongqing Genrix Biopharmaceutical | 9.20B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.98B |
| Sino Biological,Inc. | 8.31B |
| Daan Gene | 8.14B |
| Zhejiang Ausun Pharmaceutical | 8.11B |